Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Consumer Defensive

Financial

Shareholders Vote on Hammerhead Deal
Shareholders Vote on Hammerhead Deal
Financial

Healthcare

Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Healthcare

Industrial

Ecarx SPAC deal, Geely-Backed EV Goes Public with SPAC
Ecarx SPAC deal, Geely-Backed EV Goes Public with SPAC
Industrial

Technology

Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Technology

Communication

Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Communication
Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Consumer Defensive
Ecarx SPAC deal, Geely-Backed EV Goes Public with SPAC
Ecarx SPAC deal, Geely-Backed EV Goes Public with SPAC

Financial

Financial

Communication

Procaps Revenue Woes $5 Million
Procaps Revenue Woes $5 Million
Communication
AIM Immunotech FDA Lifts Hold, Stock Surges 25%
AIM Immunotech FDA Lifts Hold, Stock Surges 25%

Consumer Cyclical

Consumer Cyclical

Healthcare

Acumen Pharmaceuticals $130 Million Offering
Acumen Pharmaceuticals $130 Million Offering
Healthcare

Industrial

Arteris IP Acquires Semifore to Accelerate SoC Development
Arteris IP Acquires Semifore to Accelerate SoC Development
Industrial

Technology

Most Read ☄

18°C

6 km (1)

767.87

TV Guide

9 live

Most Read ☄

Important Read ☄

Most Read ☄

Follow Us

©2023 Copyright Pennystocks